Abstract | BACKGROUND:
Nocturnal bruxism (tooth clenching and/or grinding during sleep) affects a significant proportion of the population. Its etiology remains uncertain, and no entirely satisfactory treatment is available. METHOD: This is an observational report of four depressed individuals selected from one psychiatrist's practice within an urban hospital's psychopharmacology clinic. Psychiatric diagnoses were made according to DSM-III-R criteria. Nocturnal bruxism was determined on the basis of dental examination and/or self-reported nocturnal tooth clenching and/or grinding. RESULTS: CONCLUSION: These observations, which should be confirmed by a controlled study, suggest an association between serotonin selective reuptake inhibitor (SSRI) treatment and the onset or exacerbation of nocturnal bruxism. In addition, they suggest that a decrease in SSRI dosage or the addition of buspirone may relieve SSRI-associated nocturnal bruxism.
|
Authors | J M Ellison, P Stanziani |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 54
Issue 11
Pg. 432-4
(Nov 1993)
ISSN: 0160-6689 [Print] United States |
PMID | 8270587
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Serotonin Uptake Inhibitors
- Fluoxetine
- 1-Naphthylamine
- Sertraline
- Buspirone
|
Topics |
- 1-Naphthylamine
(administration & dosage, adverse effects, analogs & derivatives)
- Adult
- Bruxism
(chemically induced, prevention & control)
- Buspirone
(therapeutic use)
- Depressive Disorder
(drug therapy)
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Fluoxetine
(administration & dosage, adverse effects)
- Humans
- Selective Serotonin Reuptake Inhibitors
(administration & dosage, adverse effects)
- Sertraline
- Sleep
|